135 related articles for article (PubMed ID: 19605943)
1. No association of three GRIN2B polymorphisms with lithium response in bipolar patients.
Szczepankiewicz A; Skibińska M; Suwalska A; Hauser J; Rybakowski JK
Pharmacol Rep; 2009; 61(3):448-52. PubMed ID: 19605943
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of three GRIN2B polymorphisms with bipolar disorder.
Szczepankiewicz A; Skibinska M; Rybakowski J; Leszczynska-Rodziewicz A; Tomaszewska M; Twarowska-Hauser J
World J Biol Psychiatry; 2009; 10(4 Pt 2):469-73. PubMed ID: 19005876
[TBL] [Abstract][Full Text] [Related]
3. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients.
Rybakowski JK; Skibinska M; Suwalska A; Leszczynska-Rodziewicz A; Kaczmarek L; Hauser J
Hum Psychopharmacol; 2011 Mar; 26(2):168-71. PubMed ID: 21437990
[TBL] [Abstract][Full Text] [Related]
4. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
[TBL] [Abstract][Full Text] [Related]
5. Stargazin involvement with bipolar disorder and response to lithium treatment.
Silberberg G; Levit A; Collier D; St Clair D; Munro J; Kerwin RW; Tondo L; Floris G; Breen G; Navon R
Pharmacogenet Genomics; 2008 May; 18(5):403-12. PubMed ID: 18408563
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels.
Martucci L; Wong AH; De Luca V; Likhodi O; Wong GW; King N; Kennedy JL
Schizophr Res; 2006 Jun; 84(2-3):214-21. PubMed ID: 16549338
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.
Szczepankiewicz A; Rybakowski JK; Suwalska A; Hauser J
Neuro Endocrinol Lett; 2011; 32(4):545-51. PubMed ID: 21876507
[TBL] [Abstract][Full Text] [Related]
8. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
Mitjans M; Arias B; Jiménez E; Goikolea JM; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
J Clin Psychopharmacol; 2015 Oct; 35(5):600-4. PubMed ID: 26267417
[TBL] [Abstract][Full Text] [Related]
9. Response to lithium in bipolar disorder: clinical and genetic findings.
Rybakowski JK
ACS Chem Neurosci; 2014 Jun; 5(6):413-21. PubMed ID: 24625017
[TBL] [Abstract][Full Text] [Related]
10. Analysis of polymorphisms in the alpha-subunit of the olfactory G-protein Golf in lithium-treated bipolar patients.
Zill P; Malitas PN; Bondy B; Engel R; Boufidou F; Behrens S; Alevizos BE; Nikolaou CK; Christodoulou GN
Psychiatr Genet; 2003 Jun; 13(2):65-9. PubMed ID: 12782961
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with lithium efficacy in bipolar disorder.
Rybakowski JK
Harv Rev Psychiatry; 2014; 22(6):353-7. PubMed ID: 25377609
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.
Hou L; Heilbronner U; Degenhardt F; Adli M; Akiyama K; Akula N; Ardau R; Arias B; Backlund L; Banzato CEM; Benabarre A; Bengesser S; Bhattacharjee AK; Biernacka JM; Birner A; Brichant-Petitjean C; Bui ET; Cervantes P; Chen GB; Chen HC; Chillotti C; Cichon S; Clark SR; Colom F; Cousins DA; Cruceanu C; Czerski PM; Dantas CR; Dayer A; Étain B; Falkai P; Forstner AJ; Frisén L; Fullerton JM; Gard S; Garnham JS; Goes FS; Grof P; Gruber O; Hashimoto R; Hauser J; Herms S; Hoffmann P; Hofmann A; Jamain S; Jiménez E; Kahn JP; Kassem L; Kittel-Schneider S; Kliwicki S; König B; Kusumi I; Lackner N; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Jaramillo CAL; MacQueen G; Manchia M; Martinsson L; Mattheisen M; McCarthy MJ; McElroy SL; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Ösby U; Ozaki N; Perlis RH; Pfennig A; Reich-Erkelenz D; Rouleau GA; Schofield PR; Schubert KO; Schweizer BW; Seemüller F; Severino G; Shekhtman T; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Smoller JW; Squassina A; Stamm T; Stopkova P; Tighe SK; Tortorella A; Turecki G; Volkert J; Witt S; Wright A; Young LT; Zandi PP; Potash JB; DePaulo JR; Bauer M; Reininghaus EZ; Novák T; Aubry JM; Maj M; Baune BT; Mitchell PB; Vieta E; Frye MA; Rybakowski JK; Kuo PH; Kato T; Grigoroiu-Serbanescu M; Reif A; Del Zompo M; Bellivier F; Schalling M; Wray NR; Kelsoe JR; Alda M; Rietschel M; McMahon FJ; Schulze TG
Lancet; 2016 Mar; 387(10023):1085-1093. PubMed ID: 26806518
[TBL] [Abstract][Full Text] [Related]
13. The pharmacogenetics of lithium response depends upon clinical co-morbidity.
Bremer T; Diamond C; McKinney R; Shehktman T; Barrett TB; Herold C; Kelsoe JR
Mol Diagn Ther; 2007; 11(3):161-70. PubMed ID: 17570738
[TBL] [Abstract][Full Text] [Related]
14. Positive association between GRIN2B gene and bipolar disorder in the Chinese Han Population.
Zhao Q; Che R; Zhang Z; Wang P; Li J; Li Y; Huang K; Tang W; Feng G; Lindpaintner K; He L; Shi Y
Psychiatry Res; 2011 Jan; 185(1-2):290-2. PubMed ID: 20537720
[TBL] [Abstract][Full Text] [Related]
15. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
[TBL] [Abstract][Full Text] [Related]
16. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.
Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Słopień A; Czerski PM; Leszczyńska-Rodziewicz A; Hauser J
Pharmacol Rep; 2005; 57(6):761-5. PubMed ID: 16382194
[TBL] [Abstract][Full Text] [Related]
17. GADL1 gene polymorphisms and lithium response in bipolar I disorder: lack of association from an Indian population.
Kotambail A; Mathur A; Bhat SM; Rai PS; Sharma PS; Satyamoorthy K
Psychiatr Genet; 2015 Feb; 25(1):39-40. PubMed ID: 25415457
[No Abstract] [Full Text] [Related]
18. Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease.
Seripa D; Matera MG; Franceschi M; Bizzarro A; Paris F; Cascavilla L; Rinaldi M; Panza F; Solfrizzi V; Daniele A; Masullo C; Dallapiccola B; Pilotto A
Dement Geriatr Cogn Disord; 2008; 25(3):287-92. PubMed ID: 18303265
[TBL] [Abstract][Full Text] [Related]
19. Association study of polymorphisms in N-methyl-D-aspartate receptor 2B subunits (GRIN2B) gene with Korean alcoholism.
Kim JH; Park M; Yang SY; Jeong BS; Yoo HJ; Kim JW; Chung JH; Kim SA
Neurosci Res; 2006 Oct; 56(2):220-3. PubMed ID: 16911840
[TBL] [Abstract][Full Text] [Related]
20. Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype.
Dalvie S; Horn N; Nossek C; van der Merwe L; Stein DJ; Ramesar R
Afr J Psychiatry (Johannesbg); 2010 Sep; 13(4):297-301. PubMed ID: 20957330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
